Tuesday, October 12, 2021 12:47:25 AM
I saw this on the HotCopper boards:
5 announcements about to drop as per recent online company update
1. Proof of concept delivery of genetically modified cells - before end 2021
2. Proof of concept impact of telomerase in mouse model (anti aging application that is by no means certain but enormous market if it works) - before end 2021
3. Japan approval coming - either December or January
4. Outpatient C-Code/TPT outpatient burns Q1 2022
5. FDA approval new ease of use RECELL device (for vitiligo and outpatient burns) H1 2022
Also discussed by the CEO was the "enormous revenue" expected from vitiligo sales as the only curative treatment ever invented.
Recent RCEL News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/31/2026 08:54:20 PM
- AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference • GlobeNewswire Inc. • 02/23/2026 09:15:00 PM
- AVITA Medical to Host Investor Webinar Briefing • GlobeNewswire Inc. • 02/13/2026 02:15:00 PM
- AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/12/2026 09:01:00 PM
- Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies • GlobeNewswire Inc. • 01/25/2026 10:30:00 PM
- AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook • GlobeNewswire Inc. • 01/13/2026 01:25:00 PM
- AVITA Medical Announces Changes to its Board of Directors • GlobeNewswire Inc. • 01/05/2026 09:05:00 PM
- AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/18/2025 09:15:00 PM
- AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference • GlobeNewswire Inc. • 11/24/2025 09:15:00 PM
- AVITA Medical to Host Investor Webinar Briefing • GlobeNewswire Inc. • 11/09/2025 10:00:00 PM
- AVITA® Medical Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/06/2025 09:05:00 PM
- Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment • GlobeNewswire Inc. • 11/03/2025 01:30:00 PM
- AVITA Medical to Announce Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 10/29/2025 08:15:00 PM
- AVITA Medical Welcomes Support for RECELL® in Burns in Australia • GlobeNewswire Inc. • 10/28/2025 08:30:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/17/2025 10:05:58 PM
- Avita Medical Ltd stock tumbles after CEO exit and Board shake-up • IH Market News • 10/17/2025 02:48:24 PM
- AVITA Medical Announces CEO Transition • GlobeNewswire Inc. • 10/16/2025 10:15:00 PM
- Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL • PR Newswire (US) • 10/08/2025 09:44:00 PM
- CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds • GlobeNewswire Inc. • 10/01/2025 12:30:00 PM
- AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe • GlobeNewswire Inc. • 09/14/2025 11:00:00 PM
- Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical’s RECELL® System • GlobeNewswire Inc. • 09/04/2025 11:45:00 AM
- AVITA Medical Announces September Investor Conference Participation • GlobeNewswire Inc. • 08/21/2025 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2025 09:16:38 PM
- AVITA Medical Successfully Completes Australian Equity Raise • GlobeNewswire Inc. • 08/12/2025 12:30:00 PM
- AVITA Medical to Host Investor Webinar Briefing • GlobeNewswire Inc. • 08/10/2025 11:00:00 PM
